2 minute read

at the 38th Annual EAU Congress

Top-3 Best Patient Poster Award 2023 – 1st place prize

R. Giles, Duivendrecht, The Netherlands

Advertisement

- Handed out by M. Jewett

Patient Day

Friday, 10 March

Best paper published in 2023 by YAU

T. Piramide, Turin, Italy

- Handed out by J. Gómez Rivas

YAU Meeting

Friday, 10 March

Section Awards

Saturday, 11 March

Prize for the Best Paper published on Fundamental Research in the Urological Literature

L. Au, E. Hatipoglu, M. Robert De Massy, K. Litchfield, G. Beattie, A. Rowan, D. Schnidrig, R. Thompson, F. Byrne, S. Horswell, N. Fotiadis, S. Hazell, D. Nicol, S. Shepherd, A. Fendler, R. Mason, L. Del Rosario, K. Edmonds, K. Lingard, S. Sarker, M. Mangwende, E. Carlyle, J. Attig, K. Joshi, I. Uddin, P. Becker, M. Werner Sunderland, A. Akarca, I. Puccio, W. Yang, T. Lund, K. Dhillon, M. Vasquez, E. Ghorani, H. Xu, C. Spencer, J. López, A. Green, U. Mahadeva, E. Borg, M. Mitchison, D. Moore, I. Proctor, M. Falzon, L. Pickering, A. Furness, J. Reading, R. Salgado, T. Marafioti, M. Jamal-Hanjani, on behalf of the PEACE Consortium, G. Kassiotis, B. Chain,J. Larkin, C. Swanton, S. Quezada, S. Turajlic (London, Sutton, United Kingdom; Bizkaia, Spain; Melbourne, Australia; Antwerp, Belgium)

For the paper: “Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma” Cancer Cell 39 (2021); https://doi.org/10.1016/j.ccell.2021.10.001

- Handed out by C. Chapple

First Prize for the Best Abstract (Oncology)

A. Contreras-Sanz, M. Reike, G. Negri, Z. Htoo, S. Spencer Miko, K. Nielsen, M. Roberts, J. Scurll, K. Ikeda, G. Wang, R. Seiler, G. Morin, P. Black (Vancouver, Canada)

For the abstract: “Proteomic profiling of muscle invasive bladder cancer treated with neoadjuvant chemotherapy”

- Accepted by M. Reike, handed out by A. Stenzl

First Prize for the Best Abstract (Non-Oncology)

M. Kasten, O. Gross, M. Wettstein, C. Anderson, V. Birkhäuser, J. Borer, M. Koschorke, S. Mccallin, U. Mehnert, H. Sadri, L. Stächele, T. Kessler, L. Leitner (Zürich, Switzerland)

For the abstract: “Similar artefact susceptibility for water- and airfilled urodynamic systems: Results from a randomized controlled non-inferiority trial”

Supported by the IBSA

- From left to right: A. Stenzl, M. Kasten, G. Villa (IBSA)

Top-3 Best Patient Poster Award 2023 – 2nd place prize

A. Filicevas, Brussels, Belgium

Top-3 Best Patient Poster Award 2023 – 3rd place prize

A. Lawler, London, United Kingdom

Best abstract published in 2023 by YAU

G. Gandaglia, Milan, Italy

Best reviewer published in 2023 by YAU

R. Bertolo, Rome, Italy

Prize for the Best Paper published on Clinical Research in the Urological Literature

G. Basile, M. Bandini, E. Gibb, J. Ross, D. Raggi, L. Marandino, T. Costa De Padua, E. Crupi, R. Colombo, M. Colecchia, R. Lucianò, L. Nocera, M. Moschini, A. Briganti, F. Montorsi, A. Necchi (Milan, Italy; Vancouver, Canada; Massachusetts, New York, United States of America)

For the paper: “Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial” Clin Cancer Res (2022); https://doi.org/10.1158/1078-0432.CCR-22-2158040

- Handed out by C. Chapple

Award Gallery

Saturday, 11 March

Second Prize for the Best Abstract (Oncology)

C. Micoli, A. Crippa, A. Discacciati, H. Vigneswaran, T. Palsdottir, M. Clements, M. Aly, J. Adolfsson, W. Fredrik, P. Wiklund, T. James, J. Lindberg, H. Grönberg, L. Egevad, T. Nordström, M. Eklund (Solna, Sweden)

For the abstract: “The Stockholm3 prostate cancer screening trial (STHLM3): An interim analysis of mortality results after 6.5 years of follow-up”

- Handed out by A. Stenzl

Best Scientific Paper Award 2023 published in European Urology

S. Siva, M. Bressel, S. Wood, M. Shaw, S. Loi, S. Sandhu, B. Tran, A. Azad, J. Lewin, K. Cuff, H. Liu, D. Moon, J. Goad, L-M. Wong, M. LimJoon, J. Mooi, S. Chander, D. Murphy, N. Lawrentschuk, D. Pryor (Melbourne, Brisbane, Australia)

For the paper: “Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma— The RAPPORT Trial”

European Urology; Volume 81, Issue 4, P364-372, April 1, 2022

Supported by ELSEVIER

- From left to right: J. Catto, D. Murphy on behalf of S. Siva, B. Chen (ELSEVIER)

This article is from: